Tyler Bussian
Stock Analyst at Brookline Capital
(0.22)
# 4,094
Out of 4,825 analysts
5
Total ratings
25%
Success rate
-19.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tyler Bussian
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COCH Envoy Medical | Initiates: Buy | $9 | $1.40 | +542.86% | 1 | Oct 14, 2024 | |
| CRVO CervoMed | Initiates: Buy | $63 | $9.06 | +595.36% | 1 | Jul 8, 2024 | |
| IMUX Immunic | Initiates: Buy | $10 | $0.99 | +910.00% | 1 | Apr 5, 2024 | |
| ANVS Annovis Bio | Downgrades: Hold | $9 | $1.49 | +504.03% | 2 | Feb 28, 2024 |
Envoy Medical
Oct 14, 2024
Initiates: Buy
Price Target: $9
Current: $1.40
Upside: +542.86%
CervoMed
Jul 8, 2024
Initiates: Buy
Price Target: $63
Current: $9.06
Upside: +595.36%
Immunic
Apr 5, 2024
Initiates: Buy
Price Target: $10
Current: $0.99
Upside: +910.00%
Annovis Bio
Feb 28, 2024
Downgrades: Hold
Price Target: $9
Current: $1.49
Upside: +504.03%